SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-18-066068
Filing Date
2018-12-21
Accepted
2018-12-21 16:51:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 tv509667_424b3.htm 424B3 122389
2 GRAPHIC tv508725_img1.jpg GRAPHIC 11191
3 GRAPHIC tv508725_img2.jpg GRAPHIC 11238
  Complete submission text file 0001144204-18-066068.txt   154640
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-228770 | Film No.: 181250213
SIC: 8731 Services-Commercial Physical & Biological Research